Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,545 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
Onuma Y, Dudek D, Thuesen L, Webster M, Nieman K, Garcia-Garcia HM, Ormiston JA, Serruys PW. Onuma Y, et al. Among authors: webster m. JACC Cardiovasc Interv. 2013 Oct;6(10):999-1009. doi: 10.1016/j.jcin.2013.05.017. JACC Cardiovasc Interv. 2013. PMID: 24156961 Free article. Clinical Trial.
Drug-eluting stents and late stent thrombosis.
Webster MW, Ormiston JA. Webster MW, et al. Lancet. 2007 Sep 15;370(9591):914-5. doi: 10.1016/S0140-6736(07)61424-X. Lancet. 2007. PMID: 17869619 No abstract available.
Sorting out drug-eluting stents.
Webster MW, Ormiston JA. Webster MW, et al. Lancet. 2010 Mar 27;375(9720):1060-2. doi: 10.1016/S0140-6736(10)60402-3. Epub 2010 Mar 16. Lancet. 2010. PMID: 20231035 No abstract available.
Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters a feasibility study.
Bruining N, de Winter S, Roelandt JR, Regar E, Heller I, van Domburg RT, Hamers R, Onuma Y, Dudek D, Webster MW, Thuesen L, Ormiston JA, Cheong WF, Miquel-Hebert K, Veldhof S, Serruys PW. Bruining N, et al. JACC Cardiovasc Interv. 2010 Apr;3(4):449-56. doi: 10.1016/j.jcin.2010.02.004. JACC Cardiovasc Interv. 2010. PMID: 20398874 Free article. Clinical Trial.
Stent thrombosis: has the firestorm been extinguished?
Ormiston JA, Webster MW. Ormiston JA, et al. Lancet. 2012 Apr 14;379(9824):1368-9. doi: 10.1016/S0140-6736(12)60440-1. Epub 2012 Mar 23. Lancet. 2012. PMID: 22445240 No abstract available.
Drug-eluting stents--SORTed.
Webster MW, Ormiston JA. Webster MW, et al. Lancet. 2015 Apr 18;385(9977):1487-9. doi: 10.1016/S0140-6736(14)62009-2. Epub 2015 Jan 16. Lancet. 2015. PMID: 25601787 No abstract available.
Impact of the Everolimus-eluting Bioresorbable Scaffold in Coronary Atherosclerosis.
Campos CM, Garcia-Garcia HM, Muramatsu T, de Araujo Gonçalves P, Onuma Y, Dudek D, Thuesen L, Webster MW, Kitslaar P, Veldhof S, Reiber JH, Nieman K, Ormiston JA, Serruys PW. Campos CM, et al. Among authors: webster mw. Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):109-16. doi: 10.1016/j.rec.2015.07.027. Epub 2015 Dec 28. Rev Esp Cardiol (Engl Ed). 2016. PMID: 26739828 Clinical Trial.
1,545 results